Antihemophilic Factor (Recombinant [Pegylated]) and Juluca

• Generic Name: antihemophilic factor
• Dosage Forms: n.a.
• Other Brand Names:

  Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur

Antihemophilic factor is a naturally occurring protein in the blood that helps blood to clot. A lack of antihemophilic factor VIII is the cause of hemophilia A. Human antihemophilic factor works by temporarily raising levels of factor VIII in the blood to aid in clotting.

Human antihemophilic factor is used to treat or prevent bleeding episodes in people with hemophilia A. It is also used to control bleeding related to surgery or dentistry in a person with hemophilia.

Human antihemophilic factor is not for use in people with von Willebrand disease.

Human antihemophilic factor may also be used for purposes not listed in this medication guide.

• Generic Name: dolutegravir / rilpivirine
• Dosage Forms: tablet, film coated
• Other Brand Names: Juluca

Juluca contains a combination of dolutegravir and rilpivirine. Dolutegravir and rilpivirine are antiviral medicines that prevents human immunodeficiency virus (HIV) from multiplying in your body.

Juluca is used to treat HIV, the virus that can cause the acquired immunodeficiency syndrome (AIDS).

Juluca is not a cure for HIV or AIDS.

Juluca is for use only in people who have been successfully treated with other antiviral medications for at least 6 months.